Previous 10 | Next 10 |
Summary I called InMode a buy in June before it rallied as much as 58%. We've pulled back a bunch, and I think we likely have a local bottom in place. I am reloading on InMode as I think it's ready for another rally. This past June I posted a bull thesis on medical d...
InMode to Present at the Baird 2022 Global Healthcare Conference PR Newswire YOKNEAM, Israel , Aug. 30, 2022 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Yair Malca ...
The popularity of cosmetic procedures is unquestionably on the rise. Yet two major players in the space have seen their stocks struggle this year. Major pharmaceutical AbbVie (NYSE: ABBV) is plagued by concerns about the impending patent cliff on its top-selling drug. At the sam...
InMode to Participate at the 7th Annual Needham Virtual Med Tech & Diagnostics 1-on-1 Conference InMode to Participate at the 7th Annual Needham Virtual Med Tech & Diagnostics 1-on-1 Conference PR Newswire YOKNEAM, Israel , Aug. 8, 2022 /PRNew...
Shareholders of medical technology company InMode (NASDAQ: INMD) have not had a great 2022; the stock has fallen roughly 50% since the beginning of the year. Sometimes stocks fall because something bad happens within a business. But stocks can fall for no reason at all during be...
Shares of medical device company InMode (NASDAQ: INMD) jumped 48.3% in July, according to data provided by S&P Global Market Intelligence . The stock performed mostly in line with the S&P 500 during the month with the exception of two monster days. The first cam...
InMode is up more than 50% since July 1 on higher guidance for FY22 and yet another record quarter in Q2. InMode's business has never been in better shape from a fundamental analysis point of view - its growing internationally, successfully launching new products and maintaining insan...
INMD stock will likely double, given its aggressive international expansion and entrance into the medical segment. The fact that INMD continues to report stellar gross margins of over 80%, underscores its robust profitability and excellent cost management thus far. Therefore, we e...
Image source: The Motley Fool. InMode Ltd. (NASDAQ: INMD) Q2 2022 Earnings Call Jul 28, 2022 , 8:30 a.m. ET Operator Continue reading For further details see: InMode Ltd. (INMD) Q2 2022 Earnings Call Transcript
Shares of medical-device company InMode (NASDAQ: INMD) surged on Thursday after the company reported financial results for the second quarter of 2022. The company keeps beating expectations, and investors are celebrating it today. As of 3 p.m. ET, InMode stock was up 14%. In Q2,...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 06:00:08 ET Matthew Taylor from Jefferies issued a price target of $19.00 for INMD on 2024-07-23 05:00:00. The adjusted price target was set to $19.00. At the time of the announcement, INMD was trading at $17.75. The overall price target consensus is at $34.50...
Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling PR Newswire IRVINE, Calif. , July 17, 2024 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technolog...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 5.6% to $127.4 on volume of 368,729,821 shares Maxeon Solar Technologies Ltd. (MAXN) rose 14.2% to $0.2407 on volume of 294,399,898 shares Kazia Therapeutics Limited (KZIA) rose 85.6% to $1.24 on volume ...